Sartorius Aktiengesellschaft (0NIQ.L)
EUR 192.8
(5.7%)
EUR 192.8
(5.7%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 205.2 Million EUR | -69.74% |
| 2022 | 678.1 Million EUR | 112.65% |
| 2021 | 318.88 Million EUR | 51.78% |
| 2020 | 210.09 Million EUR | 34.08% |
| 2019 | 156.69 Million EUR | 10.86% |
| 2018 | 141.34 Million EUR | 23.2% |
| 2017 | 114.73 Million EUR | 11.46% |
| 2016 | 102.93 Million EUR | 20.44% |
| 2015 | 85.46 Million EUR | 94.39% |
| 2014 | 43.96 Million EUR | -8.19% |
| 2013 | 47.88 Million EUR | -1.29% |
| 2012 | 48.51 Million EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 36.7 Million EUR | 336.9% |
| 2024 Q2 | 23.9 Million EUR | -34.88% |
| 2024 Q3 | 14.2 Million EUR | -40.59% |
| 2023 FY | 205.2 Million EUR | -69.74% |
| 2023 Q4 | 8.4 Million EUR | -2.33% |
| 2023 Q2 | 95 Million EUR | 2.04% |
| 2023 Q1 | 93.1 Million EUR | -38.91% |
| 2023 Q3 | 8.6 Million EUR | -90.95% |
| 2022 Q2 | 165.8 Million EUR | -19.36% |
| 2022 Q1 | 205.6 Million EUR | 775.34% |
| 2022 FY | 678.1 Million EUR | 112.65% |
| 2022 Q3 | 154.2 Million EUR | -7.0% |
| 2022 Q4 | 152.4 Million EUR | -1.17% |
| 2021 Q2 | 108.1 Million EUR | 19.71% |
| 2021 Q4 | 23.48 Million EUR | -77.76% |
| 2021 FY | 318.88 Million EUR | 51.78% |
| 2021 Q1 | 90.3 Million EUR | 40.88% |
| 2021 Q3 | 105.6 Million EUR | -2.31% |
| 2020 Q1 | 46.2 Million EUR | 30.54% |
| 2020 Q2 | 33.9 Million EUR | -26.62% |
| 2020 Q3 | 66.2 Million EUR | 95.28% |
| 2020 Q4 | 64.09 Million EUR | -3.18% |
| 2020 FY | 210.09 Million EUR | 34.08% |
| 2019 Q3 | 39 Million EUR | -12.36% |
| 2019 Q1 | 37.8 Million EUR | -24.31% |
| 2019 FY | 156.69 Million EUR | 10.86% |
| 2019 Q4 | 35.39 Million EUR | -9.25% |
| 2019 Q2 | 44.5 Million EUR | 17.72% |
| 2018 Q2 | 30.7 Million EUR | 15.41% |
| 2018 FY | 141.34 Million EUR | 23.2% |
| 2018 Q4 | 49.94 Million EUR | 46.46% |
| 2018 Q1 | 26.6 Million EUR | -42.59% |
| 2018 Q3 | 34.1 Million EUR | 11.07% |
| 2017 FY | 114.73 Million EUR | 11.46% |
| 2017 Q1 | 26.6 Million EUR | 17.53% |
| 2017 Q2 | 19.4 Million EUR | -27.07% |
| 2017 Q3 | 22.3 Million EUR | 14.95% |
| 2017 Q4 | 46.33 Million EUR | 107.76% |
| 2016 Q2 | 29.1 Million EUR | 19.75% |
| 2016 FY | 102.93 Million EUR | 20.44% |
| 2016 Q4 | 22.63 Million EUR | -15.87% |
| 2016 Q3 | 26.9 Million EUR | -7.56% |
| 2016 Q1 | 24.3 Million EUR | 30.92% |
| 2015 Q3 | 29 Million EUR | 19.83% |
| 2015 FY | 85.46 Million EUR | 94.39% |
| 2015 Q2 | 24.2 Million EUR | 74.1% |
| 2015 Q1 | 13.9 Million EUR | 45.34% |
| 2015 Q4 | 18.56 Million EUR | -36.0% |
| 2014 Q2 | 10.6 Million EUR | 0.95% |
| 2014 Q1 | 10.5 Million EUR | 23.73% |
| 2014 Q3 | 13.2 Million EUR | 24.53% |
| 2014 Q4 | 9.56 Million EUR | -27.55% |
| 2014 FY | 43.96 Million EUR | -8.19% |
| 2013 Q2 | 14.3 Million EUR | 11.72% |
| 2013 Q1 | 12.8 Million EUR | 10.25% |
| 2013 Q3 | 12.3 Million EUR | -13.99% |
| 2013 Q4 | 8.48 Million EUR | -31.01% |
| 2013 FY | 47.88 Million EUR | -1.29% |
| 2012 FY | 48.51 Million EUR | 0.0% |
| 2012 Q4 | 11.61 Million EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Cegedim SA | -7.4 Million EUR | 2870.352% |
| Guerbet SA | 23.86 Million EUR | -759.801% |
| Nexus AG | 24.03 Million EUR | -753.897% |
| Bastide Le Confort Médical SA | -900 Thousand EUR | 22900.0% |
| Revenio Group Oyj | 19.1 Million EUR | -973.84% |
| Drägerwerk AG & Co. KGaA | 110.43 Million EUR | -85.814% |
| LNA Santé SA | 23.4 Million EUR | -776.586% |
| Siemens Healthineers AG | 1.94 Billion EUR | 89.434% |
| Medios AG | 18.81 Million EUR | -990.909% |
| Equasens Société anonyme | 47.04 Million EUR | -336.16% |
| Stratec SE | 13.06 Million EUR | -1470.368% |